secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001171843-22-007076
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

The Joint Corp Q3 revenue +27% to $26.6M; net income drops to $491k; lowers EBITDA guidance
--------------------------------------------------------------------------------

- Revenue $26.6M (+27% YoY); net income $491k ($0.03 EPS) vs $1.9M ($0.13) in Q3 2021.
- System-wide sales $110.4M (+18%); system-wide comp sales +6%; 38 clinics opened in quarter.
- Total clinics 805 (690 franchised, 115 company-owned/managed) at Sept 30, 2022.
- Adjusted EBITDA $3.1M vs $3.3M last year; 2022 guidance: revenue $100-102M, EBITDA $11.5-12.5M (lowered from $12-14M).
- Reacquired Philadelphia RD territory; acquired 2 clinics and sold 1 corporate clinic post-quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000117184322007076/0001171843-22-007076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000117184322007076/f8k_110322.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-007076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer